A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993

Archives of Disease in Childhood

Volumn 75, Issue 1, 1996, Pages 17-24

  Donadieu, Jean ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Langerhans' cell histiocytosis; Retrospective survey; Vinblastine; VP 16

Indexed keywords

CORTICOSTEROID; ETOPOSIDE; VINBLASTINE;

ADOLESCENT; AGE; ARTICLE; BONE DISEASE; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CHILD; DIABETES INSIPIDUS; DISEASE COURSE; FEMALE; FOLLOW UP; HISTIOCYTOSIS; HUMAN; INFANT; LANGERHANS CELL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0030014056     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.1.17     Document Type: Article

References (34)

1. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995; 127: 1-11.
2. Avery ME, Mc Affe, Guild HG. The course and prognosis of reticuloendotheliosis: a study of 40 cases. Am J Med 1957; 22: 636-42.
3. Berry DH, Gresik MV, Humphrey GB. Natural history of histiocytosis X: a pediatric oncology group study. Med Pediatr Oncol 1986; 14: 1-5.
4. Broadbent V. Favourable prognostic features in histiocytosis X: bone involvement and absence of skin disease. Arch Dis Child 1986; 61: 1219-21.
5. Cartensen H, Ornvold K. The epidemiology of Langerhans' cell histiocytosis in children in Denmark 1975-1989. Med Pediatr Oncol 1993; 21: 387-8.
6. Ceci A, de Terlizzi M, Colella R, et al. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP CNR-HX '83 study. Med Pediatr Oncol 1993; 21: 259-64.
7. Chomette G, Auriol M, Ragot JP, Guilbert F. Histiocytose X des maxillaires. I. Etude anatomo-clinique à propos de 61 cas. Rev Stomatol Chir Maxillofac 1987; 88: 334-8.
8. Daneshbod K, Kissane JM. Idiopathic differentiated histiocytosis. Am J Clin Pathol 1978; 70: 381-6.
9. Dimentberg RA, Brown KL. Diagnostic evaluation of patients with histiocytosis X. J Pediatr Onhop 1990; 10: 733-41.
10. Egeler RM, de Kraker J, Voute PA. Langerhans-celhistiocytosis (histiocytosis X); 20 jaar ervaring in het Emma Kinderziekenhuis, 1969-1988. Ned Tijdschr Geneeskd 1993; 137: 955-60.
11. Greenberger JS, Crocker AC, Vawter G, Jaffe N, Cassady JR. Results of treatment of 127 patients with systemic histiocytosis. Medecine 1981; 60: 311-7.
12. Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC. Langerhans' cell histiocytosis (histiocytosis X) of bone. Cancer 1995; 76: 2471-84.
13. Komp DM , El Madhi A, Starling KA, et al. Long -term sequelae of histiocytosis X. Am J Pediatr Hematol Oncol 1981; 3: 165-8.
14. Lahey ME. Histiocytosis X - comparison of three treatment regimens. J Pediatr 1975; 87: 170-83.
15. Lahey ME. Histiocytosis X - an analysis of prognostic factors. J Pediatr 1975; 87: 184-9.
16. Leavey P, Varughese M, Breatnach F, O'Meara A. Langerhans cell histiocytosis - a 31 year review. Ir J Med Sci 1991; 60: 271-4.
17. Mac Lelland J, Broadbent V, Yeomans E, et al. Langerhans cell histiocytosis: the case for conservative treatment. Arch Dis Child 1990; 6: 301-3.
18. Nezelof C, Frileux-Herbet E, Crosnier J, et al. Disseminated histiocytosis X. Analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979; 44: 1824-38.
19. Oberman HA. Idiopathic histiocytosis. A clinicopathologic study of 40 cases and review of literature. Pediatrics 1961; 8: 307-27.
20. Raney RB Jr, D'Angio GJ. Langerhans' cell histiocytosis (histiocytosis X): experience at the Children's Hospital of Philadelphia, 1970-1984. Med Pediair Oncol 1989; 17: 20-8.
21. Rivera-Luna R, Martinez-Guerra G, Altamirano-Alvarez E, et al. Langerhans' cell histiocytosis: clinical experience with 124 patients. Pediatr Dermatol 1988; 5: 45-50.
22. Sims DG. Histiocytosis X. Follow up of 43 cases. Arch Dis Child 1977; 52: 433-40.
23. Toogood IRG. Prognostic criteria, treatment and survival in disseminated histiocytosis X. Aust Paediatr J 1979;15:91-5.
24. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans' cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994; 23: 72-80.
25. Ladisch S, Gadner H, Arico M, et al. Langerhans' cell histiocytosis-I: a randomized trial of etoposide vs vinblastine in disseminated Langerhans' cell histiocytosis. The Histiocyte Society. Med Pediatr Oncol 1994; 23: 107-10.
26. Collet D. Modelling survival data in medical research. Text in statistical science. London: Chapman and Hall, 1994.
27. Grapin C, Audry G, Josset P, et al. Histiocytosis X revealed by complex anal fistula. Eur J Pediatr Surg 1994; 4: 184-5.
28. Sheils C, Dover GJ. Frequency of congenital anomalies in patients with histiocytosis X. Am J Hematol 1989; 31: 91-5.
29. Egeler RM, Neglia JP, Puccetti DM, et al. Association of Langerhans' cell histiocytosis with malignant neoplasms. Cancer 1993; 71: 865-73.
30. Chap L, Nimer SD. Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X. Leuk Lymphoma 1994; 12: 315-6.
31. Horibe K, Matsushita T, Numata SI, et al. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for langerhans cell histiocytosis. Cancer 1993; 72: 3723-6.
32. D'Angio GJ. Langerhans cell histiocytosis and etoposide: risks vs benefits. Med Pediatr Oncol 1994; 23: 69-71.
33. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994; 69: 979-85.
34. Greinix HT, Storb R, Sanders JE, Petersen FB. Marrow transplantation for treatment of multisystem progressive Langerhans' cell histiocytosis. Bone Marrow Transplant 1992; 10:39-44.